Yi-Yu Ke

4PUBLICATIONS
36CO-AUTHORS
Molecular targetsPharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Apr 03, 2025
Author Correction: Identification of PTGR2 inhibitors as a new therapeutic strategy for diabetes and obesity.

Yi-Cheng Chang, Meng-Lun Hsieh, Hsiao-Lin Lee

|Mar 22, 2025
Identification of PTGR2 inhibitors as a new therapeutic strategy for diabetes and obesity.

Yi-Cheng Chang, Meng-Lun Hsieh, Hsiao-Lin Lee

|Apr 09, 2024
Discovery of a Long Half-Life AURKA Inhibitor to Treat MYC-Amplified Solid Tumors as a Monotherapy and in Combination with Everolimus.

Chun-Ping Chang, Teng-Kuang Yeh, Chiung-Tong Chen

|Mar 23, 2021
A highly selective and potent CXCR4 antagonist for hepatocellular carcinoma treatment.

Jen-Shin Song, Chih-Chun Chang, Chien-Huang Wu

Pageof 1